Importantly, blocking the GR with selective GR antagonists specific to liver or adipose tissue leads to a decrease in glucose levels in diabetic rodents [115,116,117,118], supporting a role of GR in hyperglycemia. Here, NR3C1 is linked to Hyperglycemia.